uniQure has presented new results from its phase 1/2 study of its gene therapy for Huntington’s disease that it said were positive, although investors are far from convinced by the data.
A 14-year study tracking NfL levels in people with the HD gene shows this tiny protein can signal disease progression many ...
According to the University of California San Francisco, Huntington’s disease affects one in every 10,000 to 20,000 people in ...
The Missouri Chapter of the Huntington's Disease Society of America will host a Team Hope walk Saturday, April 12, at Jackson ...
Researchers from Life Edit Therapeutics Inc. recently reported preclinical data on the application of their gene editing technology Life Edit CRISPR system to Huntington’s disease (HD).
Skyhawk presents today on its novel SKY-0515 small molecule RNA splicing modulator targeting Huntington's Disease to members of the Huntington's Disease Youth Organization, at the annual HYDO ...
A striking new mural in Smíchov created by local students and Colombian artist DjLu Juegasiempre raises awareness for Huntington’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback